| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | 0.54 | 0.0007 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | 0.5 | 0.1 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.33 | 1e-18 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.32 | 4e-09 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.29 | 0.3 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.28 | 3e-15 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | 0.28 | 0.4 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.28 | 1e-07 |
| mRNA | BI-2536 | FIMM | pan-cancer | AAC | 0.28 | 0.04 |
| mRNA | Imatinib | FIMM | pan-cancer | AAC | 0.28 | 0.2 |